vs

Side-by-side financial comparison of CBIZ, Inc. (CBZ) and Quanex Building Products CORP (NX). Click either name above to swap in a different company.

CBIZ, Inc. is the larger business by last-quarter revenue ($848.6M vs $495.3M, roughly 1.7× Quanex Building Products CORP). CBIZ, Inc. runs the higher net margin — 19.0% vs -55.7%, a 74.8% gap on every dollar of revenue. On growth, Quanex Building Products CORP posted the faster year-over-year revenue change (76.7% vs 1.3%). Quanex Building Products CORP produced more free cash flow last quarter ($46.2M vs $-28.5M). Over the past eight quarters, CBIZ, Inc.'s revenue compounded faster (42.1% CAGR vs 29.5%).

CBIZ, Inc. is a national provider of financial, insurance and advisory services headquartered in Independence, Ohio. CBIZ is one of the largest accounting, insurance brokerage, financial and advisory services providers in the United States with more than 120 offices and nearly 7,000 employees. Its common stock has been traded on the New York Stock Exchange since 1996, under the symbol "CBZ" since 1997.

Quanex Building Products Corporation is a leading manufacturer of engineered building components and materials. Its core offerings include insulating glass spacers, window and door systems, and cabinet furniture components, serving residential and commercial construction markets across North America and Europe, with a focus on energy-efficient, sustainable building solutions.

CBZ vs NX — Head-to-Head

Bigger by revenue
CBZ
CBZ
1.7× larger
CBZ
$848.6M
$495.3M
NX
Growing faster (revenue YoY)
NX
NX
+75.4% gap
NX
76.7%
1.3%
CBZ
Higher net margin
CBZ
CBZ
74.8% more per $
CBZ
19.0%
-55.7%
NX
More free cash flow
NX
NX
$74.7M more FCF
NX
$46.2M
$-28.5M
CBZ
Faster 2-yr revenue CAGR
CBZ
CBZ
Annualised
CBZ
42.1%
29.5%
NX

Income Statement — Q1 FY2026 vs Q3 FY2025

Metric
CBZ
CBZ
NX
NX
Revenue
$848.6M
$495.3M
Net Profit
$161.6M
$-276.0M
Gross Margin
27.9%
Operating Margin
23.2%
-54.7%
Net Margin
19.0%
-55.7%
Revenue YoY
1.3%
76.7%
Net Profit YoY
-1188.8%
EPS (diluted)
$2.63
$-6.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBZ
CBZ
NX
NX
Q1 26
$848.6M
Q4 25
$542.7M
Q3 25
$693.8M
$495.3M
Q2 25
$683.5M
$452.5M
Q1 25
$838.0M
$400.0M
Q4 24
$460.3M
$492.2M
Q3 24
$438.9M
$280.3M
Q2 24
$420.0M
$266.2M
Net Profit
CBZ
CBZ
NX
NX
Q1 26
$161.6M
Q4 25
$-79.4M
Q3 25
$30.1M
$-276.0M
Q2 25
$41.9M
$20.5M
Q1 25
$122.8M
$-14.9M
Q4 24
$-90.7M
$-13.9M
Q3 24
$35.1M
$25.4M
Q2 24
$19.8M
$15.4M
Gross Margin
CBZ
CBZ
NX
NX
Q1 26
Q4 25
-9.4%
Q3 25
13.0%
27.9%
Q2 25
12.9%
29.0%
Q1 25
27.2%
23.1%
Q4 24
-13.4%
Q3 24
16.6%
25.3%
Q2 24
12.8%
24.9%
Operating Margin
CBZ
CBZ
NX
NX
Q1 26
23.2%
Q4 25
-15.7%
Q3 25
8.5%
-54.7%
Q2 25
8.8%
9.0%
Q1 25
23.9%
-1.7%
Q4 24
-23.2%
0.6%
Q3 24
11.3%
8.4%
Q2 24
7.5%
7.8%
Net Margin
CBZ
CBZ
NX
NX
Q1 26
19.0%
Q4 25
-14.6%
Q3 25
4.3%
-55.7%
Q2 25
6.1%
4.5%
Q1 25
14.7%
-3.7%
Q4 24
-19.7%
-2.8%
Q3 24
8.0%
9.0%
Q2 24
4.7%
5.8%
EPS (diluted)
CBZ
CBZ
NX
NX
Q1 26
$2.63
Q4 25
$-1.22
Q3 25
$0.48
$-6.04
Q2 25
$0.66
$0.44
Q1 25
$1.91
$-0.32
Q4 24
$-1.84
$-0.52
Q3 24
$0.70
$0.77
Q2 24
$0.39
$0.46

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBZ
CBZ
NX
NX
Cash + ST InvestmentsLiquidity on hand
$28.7M
$66.3M
Total DebtLower is stronger
$695.6M
Stockholders' EquityBook value
$1.9B
$717.4M
Total Assets
$4.6B
$2.0B
Debt / EquityLower = less leverage
0.97×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBZ
CBZ
NX
NX
Q1 26
$28.7M
Q4 25
$18.3M
Q3 25
$17.0M
$66.3M
Q2 25
$39.8M
$62.6M
Q1 25
$8.8M
$50.0M
Q4 24
$13.8M
$97.7M
Q3 24
$1.1M
$94.0M
Q2 24
$1.1M
$56.1M
Total Debt
CBZ
CBZ
NX
NX
Q1 26
Q4 25
Q3 25
$695.6M
Q2 25
$746.4M
Q1 25
$725.2M
Q4 24
$737.2M
Q3 24
$51.4M
Q2 24
$51.5M
Stockholders' Equity
CBZ
CBZ
NX
NX
Q1 26
$1.9B
Q4 25
$1.8B
Q3 25
$1.9B
$717.4M
Q2 25
$1.9B
$1.0B
Q1 25
$1.9B
$972.1M
Q4 24
$1.8B
$1.0B
Q3 24
$927.9M
$594.1M
Q2 24
$891.4M
$566.1M
Total Assets
CBZ
CBZ
NX
NX
Q1 26
$4.6B
Q4 25
$4.4B
Q3 25
$4.5B
$2.0B
Q2 25
$4.5B
$2.3B
Q1 25
$4.6B
$2.2B
Q4 24
$4.5B
$2.3B
Q3 24
$2.1B
$872.5M
Q2 24
$2.2B
$837.2M
Debt / Equity
CBZ
CBZ
NX
NX
Q1 26
Q4 25
Q3 25
0.97×
Q2 25
0.75×
Q1 25
0.75×
Q4 24
0.73×
Q3 24
0.09×
Q2 24
0.09×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBZ
CBZ
NX
NX
Operating Cash FlowLast quarter
$-25.5M
$60.7M
Free Cash FlowOCF − Capex
$-28.5M
$46.2M
FCF MarginFCF / Revenue
-3.4%
9.3%
Capex IntensityCapex / Revenue
2.9%
Cash ConversionOCF / Net Profit
-0.16×
TTM Free Cash FlowTrailing 4 quarters
$240.5M
$27.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBZ
CBZ
NX
NX
Q1 26
$-25.5M
Q4 25
$143.6M
Q3 25
$24.0M
$60.7M
Q2 25
$113.1M
$28.5M
Q1 25
$-88.3M
$-12.5M
Q4 24
$55.5M
$5.5M
Q3 24
$43.7M
$46.4M
Q2 24
$88.2M
$33.1M
Free Cash Flow
CBZ
CBZ
NX
NX
Q1 26
$-28.5M
Q4 25
$141.7M
Q3 25
$22.1M
$46.2M
Q2 25
$105.2M
$13.6M
Q1 25
$-93.4M
$-24.1M
Q4 24
$52.3M
$-8.2M
Q3 24
$41.1M
$40.1M
Q2 24
$86.3M
$25.5M
FCF Margin
CBZ
CBZ
NX
NX
Q1 26
-3.4%
Q4 25
26.1%
Q3 25
3.2%
9.3%
Q2 25
15.4%
3.0%
Q1 25
-11.2%
-6.0%
Q4 24
11.4%
-1.7%
Q3 24
9.4%
14.3%
Q2 24
20.5%
9.6%
Capex Intensity
CBZ
CBZ
NX
NX
Q1 26
Q4 25
0.4%
Q3 25
0.3%
2.9%
Q2 25
1.2%
3.3%
Q1 25
0.6%
2.9%
Q4 24
0.7%
2.8%
Q3 24
0.6%
2.2%
Q2 24
0.4%
2.9%
Cash Conversion
CBZ
CBZ
NX
NX
Q1 26
-0.16×
Q4 25
Q3 25
0.79×
Q2 25
2.70×
1.39×
Q1 25
-0.72×
Q4 24
Q3 24
1.25×
1.83×
Q2 24
4.45×
2.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBZ
CBZ

Financial Services (1)$740.3M87%
Benefits and Insurance Services$108.2M13%

NX
NX

Window And Door Hardware$150.3M30%
Screens$76.8M16%
Window Profiles$68.2M14%
Spacers$54.7M11%
Wood Solutions$53.4M11%
Seals And Gaskets$29.9M6%
Access Solutions$27.4M6%
Mixing Solution$21.5M4%
Solar$5.3M1%
Product Type Other$3.3M1%

Related Comparisons